Drug Shortage Report for SANDOZ DAPAGLIFLOZIN
Report ID | 202538 |
Drug Identification Number | 02518740 |
Brand name | SANDOZ DAPAGLIFLOZIN |
Common or Proper name | DAPAGLIFLOZIN |
Company Name | SANDOZ CANADA INCORPORATED |
Market Status | MARKETED |
Active Ingredient(s) | DAPAGLIFLOZIN |
Strength(s) | 10MG |
Dosage form(s) | TABLET |
Route of administration | ORAL |
Packaging size | 500FCT BO |
ATC code | A10BK |
ATC description | BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS |
Reason for shortage | Demand increase for the drug. |
Anticipated start date | |
Actual start date | 2023-08-21 |
Estimated end date | 2023-11-17 |
Actual end date | 2023-10-13 |
Shortage status | Resolved |
Updated date | 2023-11-13 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 110 RUE DE LAUZON BOUCHERVILLE, QUEBEC CANADA J4B 1E6 |
Company contact information | 1 800-361-3062 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v17 | 2023-11-13 | French | Compare |
v16 | 2023-11-13 | English | Compare |
v15 | 2023-11-06 | French | Compare |
v14 | 2023-11-06 | English | Compare |
v13 | 2023-11-06 | French | Compare |
v12 | 2023-11-06 | English | Compare |
v11 | 2023-10-23 | French | Compare |
v10 | 2023-10-23 | English | Compare |
v9 | 2023-10-10 | French | Compare |
v8 | 2023-10-10 | English | Compare |
v7 | 2023-10-02 | French | Compare |
v6 | 2023-10-02 | English | Compare |
v5 | 2023-09-25 | French | Compare |
v4 | 2023-09-25 | English | Compare |
v3 | 2023-08-22 | English | Compare |
v2 | 2023-08-21 | French | Compare |
v1 | 2023-08-21 | English | Compare |
Showing 1 to 17 of 17